Venlafaxine 25 mg Immediate Release Tablets — Generic For Effexor — TEVA

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Venlafaxine tablets are a prescription antidepressant used to treat major depressive disorder in adults. The label says the benefit of treatment was shown in short-term controlled studies, and continued use should be periodically re-evaluated for long-term usefulness.

The label warns that antidepressants, including venlafaxine, can increase the risk of suicidal thinking and behavior in children, adolescents, and young adults, especially early in treatment or when the dose changes. Patients should be monitored closely for worsening depression, unusual behavior changes, agitation, irritability, or suicidal thoughts.

Venlafaxine should not be used with MAO inhibitors, and it can interact with other serotonergic medicines or supplements. The label also warns about serotonin syndrome, sustained increases in blood pressure, angle-closure glaucoma risk in people with narrow angles, sexual dysfunction, and symptoms that can happen if the medicine is stopped too quickly.

Storage Information

protection, if needed, may be indicated if performed soon after ingestion or in symptomatic patients. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] in a dry place. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). store venlafaxine tablets? Store venlafaxine tablets at room temperature between 68°F and 77°F (20°C to 25°C).

Key Counseling Points

• Take venlafaxine exactly as prescribed.
• Do not use venlafaxine with MAO inhibitors or within the time limits listed on the label.
• Tell your healthcare provider about all other medicines and supplements you take, especially other serotonergic drugs.
• Watch for serotonin syndrome symptoms such as agitation, hallucinations, fast heartbeat, labile blood pressure, tremor, rigidity, nausea, vomiting, or diarrhea.
• Monitor for worsening depression, unusual behavior changes, or suicidal thoughts, especially early in treatment or when doses change.
• Do not stop venlafaxine suddenly unless instructed; the label recommends gradual dose reduction when possible.
• Report symptoms that may occur after dose reduction or stopping, such as dizziness, anxiety, insomnia, nausea, sweating, shock-like sensations, or flu-like symptoms.
• Blood pressure should be monitored during treatment because venlafaxine can cause sustained increases in blood pressure.
• Tell your healthcare provider if you have a history of glaucoma with narrow angles.
• Sexual side effects can occur, including decreased libido, delayed orgasm, erectile dysfunction, or ejaculatory delay.

Helpful Patient Education

Venlafaxine hydrochloride tablets are a prescription antidepressant used for the treatment of major depressive disorder. This DailyMed label information includes key safety details such as monitoring for suicidal thoughts and behavior, avoiding use with MAO inhibitors, and awareness of possible serotonin syndrome, blood pressure increases, and discontinuation symptoms.

For pharmacy education purposes, venlafaxine tablet information should be reviewed along with the full prescribing information. Patients and caregivers should pay attention to changes in mood, behavior, or side effects during treatment and report concerns to a healthcare professional.

Medication Summary last generated: 2026-07-09 03:11:43